Paul Mintz - 09 Dec 2025 Form 4/A - Amendment Insider Report for Nuo Therapeutics, Inc. (AURX)

Role
Director
Signature
/s/ David Jorden, attorney-in-fact
Issuer symbol
AURX
Transactions as of
09 Dec 2025
Transactions value $
$0
Form type
4/A - Amendment
Filing time
11 Dec 2025, 21:55:15 UTC
Date Of Original Report
11 Dec 2025
Previous filing
04 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mintz Paul Director C/O NUO THERAPEUTICS, INC., 8285 EL RIO, SUITE190, HOUSTON /s/ David Jorden, attorney-in-fact 11 Dec 2025 0001480208

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURX Common Stock Options Exercise $20K +50K +74.2% $0.40 117K 09 Dec 2025 Direct
transaction AURX Common Stock Tax liability -$20K -9.09K -7.74% $2.20 108K 09 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURX Option to purchase common stock Options Exercise $0 -50K -100% $0.00 0 31 Dec 2018 Common Stock 50K $0.40 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a net exercise of outstanding stock options. The reporting person received 40,909 shares of common stock on the net exercise of option to purchase 50,000 shares of common stock. The issuer withheld 9,091 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.20.